Zytron
- Generic Name
- Zytron
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H14Cl2NO2PS
- CAS Number
- 299-85-4
- Unique Ingredient Identifier
- IK51552IFH
- Background
Zytron (DMPA) is under investigation for the treatment and health services research of HIV, Lactation, Contraception, Postpartum Depression, and Immune Cells (Mucosal and Systemic). DMPA has been investigated for the prevention, treatment, and basic science of Weight and Microbiota.
- Associated Conditions
- -
- Associated Therapies
- -
Endometrial Biopsy in Progestin Contraceptive Users
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 52
- Registration Number
- NCT05760144
- Locations
- 🇺🇸
OHSU, Portland, Oregon, United States
The Kampala Women's Bone Study
- First Posted Date
- 2018-03-14
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 500
- Registration Number
- NCT03464266
- Locations
- 🇺🇬
Infectious Disease Institute, Kampala, Uganda
Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 460
- Registration Number
- NCT03255941
- Locations
- 🇵🇰
Aga Khan University, Karachi, Sindh, Pakistan
Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP
- Conditions
- Interventions
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Sharon Achilles
- Target Recruit Count
- 15
- Registration Number
- NCT03197961
- Locations
- 🇺🇸
Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States
The Evidence for Contraceptive Options and HIV Outcomes Trial
- First Posted Date
- 2015-09-15
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 7830
- Registration Number
- NCT02550067
- Locations
- 🇿🇦
MatCH Research Unit Commercial City, Durban, South Africa
🇿🇦Effective Care Research Unit (ECRU) Frere Maternity Hospital, East London, South Africa
🇿🇦Setshaba Research Centre, Soshanguve, South Africa
Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
- First Posted Date
- 2015-08-28
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- King Chulalongkorn Memorial Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT02534688
- Locations
- 🇹🇭
King Chulalongkorn Memmorial hospital, Bangkok, Thailand
HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 451
- Registration Number
- NCT02038335
- Locations
- 🇿🇼
UZ UCSF, Harare, Zimbabwe
Same-day Long-acting Reversible Contraception for Medication Abortion
- First Posted Date
- 2011-05-20
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Boston University
- Target Recruit Count
- 40
- Registration Number
- NCT01356927
- Locations
- 🇺🇸
Boston University Medical Center, Boston, Massachusetts, United States
Long-Acting Reversible Contraception
- Conditions
- Interventions
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2018-02-28
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 916
- Registration Number
- NCT01299116
- Locations
- 🇺🇸
Planned Parenthood Central North Carolina, Chapel Hill, North Carolina, United States
Depot Contraception With and Without Lopinavir/Ritonavir
- First Posted Date
- 2010-11-01
- Last Posted Date
- 2010-11-29
- Lead Sponsor
- St Stephens Aids Trust
- Target Recruit Count
- 10
- Registration Number
- NCT01231451
- Locations
- 🇬🇧
St Stephen's Centre, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.